Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Jan;35(1):195–197. doi: 10.1128/aac.35.1.195

In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.

F Biavasco 1, E Manso 1, P E Varaldo 1
PMCID: PMC244968  PMID: 1826593

Abstract

Seventy strains of Clostridium difficile, all isolated from symptomatic patients, were found to be uniformly susceptible to ramoplanin, a new glycolipodepsipeptide antibiotic, and to four glycopeptides (vancomycin, teicoplanin, and two semisynthetic teicoplanin derivatives). Ramoplanin is recommended for further evaluation in the treatment of C. difficile-associated disease.

Full text

PDF
195

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. G., Chang T. W., Gurwith M., Gorbach S. L., Onderdonk A. B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531–534. doi: 10.1056/NEJM197803092981003. [DOI] [PubMed] [Google Scholar]
  2. Bartlett J. G. Clostridium difficile: clinical considerations. Rev Infect Dis. 1990 Jan-Feb;12 (Suppl 2):S243–S251. doi: 10.1093/clinids/12.supplement_2.s243. [DOI] [PubMed] [Google Scholar]
  3. Bartlett J. G. Treatment of Clostridium difficile colitis. Gastroenterology. 1985 Nov;89(5):1192–1195. doi: 10.1016/0016-5085(85)90227-6. [DOI] [PubMed] [Google Scholar]
  4. Cavalleri B., Pagani H., Volpe G., Selva E., Parenti F. A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics. J Antibiot (Tokyo) 1984 Apr;37(4):309–317. doi: 10.7164/antibiotics.37.309. [DOI] [PubMed] [Google Scholar]
  5. Ciabatti R., Kettenring J. K., Winters G., Tuan G., Zerilli L., Cavalleri B. Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation. J Antibiot (Tokyo) 1989 Feb;42(2):254–267. doi: 10.7164/antibiotics.42.254. [DOI] [PubMed] [Google Scholar]
  6. Dixson S., Brumfitt W., Hamilton-Miller J. M. In vitro evaluation of ramoplanin (MDL 62198, A 16686) Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):819–821. doi: 10.1007/BF01975062. [DOI] [PubMed] [Google Scholar]
  7. Fekety R., Silva J., Buggy B., Deery H. G. Treatment of antibiotic-associated colitis with vancomycin. J Antimicrob Chemother. 1984 Dec;14 (Suppl 500):97–102. doi: 10.1093/jac/14.suppl_d.97. [DOI] [PubMed] [Google Scholar]
  8. George R. H., Symonds J. M., Dimock F., Brown J. D., Arabi Y., Shinagawa N., Keighley M. R., Alexander-Williams J., Burdon D. W. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J. 1978 Mar 18;1(6114):695–695. doi: 10.1136/bmj.1.6114.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gurusiddaiah S., Graham S. O. Some chemical and physical characteristics of pantomycin, and antiobiotic isolated from Streptomyces hygroscopicus. Antimicrob Agents Chemother. 1980 Jun;17(6):980–987. doi: 10.1128/aac.17.6.980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jorgensen J. H., Redding J. S., Maher L. A. Antibacterial activity of the new glycopeptide antibiotic SKF104662. Antimicrob Agents Chemother. 1989 Apr;33(4):560–561. doi: 10.1128/aac.33.4.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kaplan A. H., Gilligan P. H., Facklam R. R. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol. 1988 Jun;26(6):1216–1218. doi: 10.1128/jcm.26.6.1216-1218.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Larson H. E., Price A. B., Honour P., Borriello S. P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet. 1978 May 20;1(8073):1063–1066. doi: 10.1016/s0140-6736(78)90912-1. [DOI] [PubMed] [Google Scholar]
  13. Malabarba A., Trani A., Strazzolini P., Cietto G., Ferrari P., Tarzia G., Pallanza R., Berti M. Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships. J Med Chem. 1989 Nov;32(11):2450–2460. doi: 10.1021/jm00131a007. [DOI] [PubMed] [Google Scholar]
  14. Neu H. C., Neu N. M. In vitro activity of A-16686, a new glycopeptide. Chemotherapy. 1986;32(5):453–457. doi: 10.1159/000238450. [DOI] [PubMed] [Google Scholar]
  15. Pallanza R., Berti M., Scotti R., Randisi E., Arioli V. A-16686, a new antibiotic from Actinoplanes. II. Biological properties. J Antibiot (Tokyo) 1984 Apr;37(4):318–324. doi: 10.7164/antibiotics.37.318. [DOI] [PubMed] [Google Scholar]
  16. Pallanza R., Scotti R., Beretta G., Cavalleri B., Arioli V. In vitro activity of A-16686, a potential antiplaque agent. Antimicrob Agents Chemother. 1984 Oct;26(4):462–465. doi: 10.1128/aac.26.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shlaes D. M., Al-Obeid S., Shlaes J. H., Williamson R. Activity of various glycopeptides against an inducibly vancomycin-resistant strain of Enterococcus faecium (D366). J Infect Dis. 1989 Jun;159(6):1132–1135. doi: 10.1093/infdis/159.6.1132. [DOI] [PubMed] [Google Scholar]
  18. Shlaes D. M., Binczewski B. Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):106–110. doi: 10.1007/BF01963634. [DOI] [PubMed] [Google Scholar]
  19. Somner E. A., Reynolds P. E. Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob Agents Chemother. 1990 Mar;34(3):413–419. doi: 10.1128/aac.34.3.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Uttley A. H., Collins C. H., Naidoo J., George R. C. Vancomycin-resistant enterococci. Lancet. 1988 Jan 2;1(8575-6):57–58. doi: 10.1016/s0140-6736(88)91037-9. [DOI] [PubMed] [Google Scholar]
  21. Varaldo P. E., Debbia E., Schito G. C. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin. Antimicrob Agents Chemother. 1983 Mar;23(3):402–406. doi: 10.1128/aac.23.3.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. de Lalla F., Privitera G., Rinaldi E., Ortisi G., Santoro D., Rizzardini G. Treatment of Clostridium difficile-associated disease with teicoplanin. Antimicrob Agents Chemother. 1989 Jul;33(7):1125–1127. doi: 10.1128/aac.33.7.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES